CVE-2025-41090microCLAUDIA in v3.2.0 and prior has an improper access control vulnerability.
Updated under an hour ago ()
Does this affect you?
It lists no affected products yet. Add what you run and Signals checks it as products are added.
No exploitation reported and no EPSS estimate yet.
microCLAUDIA in v3.2.0 and prior has an improper access control vulnerability. This flaw allows an authenticated user to perform unauthorized actions on other organizations' systems by sending direct API requests. To do so, the attacker can use organization identifiers obtained through a compromised endpoint or deduced manually. This vulnerability allows access between tenants, enabling an attacker to list and manage remote assets, uninstall agents, and even delete vaccines configurations.
- CVSS
- 7.6 HIGH (v4.0, NVD)CVSS:4.0/AV:N/AC:L/AT:P/PR:L/UI:N/VC:H/VI:H/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
- Weakness (CWE)
- CWE-306
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- Not given
- NVD analysis
- Deferred
- Record last updated
- Oct 8, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
No affected products are listed yet.
References
- https://www.incibe.es/en/incibe-cert/notices/aviso/improper-access-control-ccn-cert-microclaudia
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.